Co-Diagnostics, Inc. Operating Lease Liability
Co-Diagnostics, Inc. (CODX) had Operating Lease Liability of $1.80 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability $1.80M.
- 2026-03-31: Operating Lease, Liability $2.03M.
- 2025-12-31: Operating Lease, Liability $1.24M.
- 2025-09-30: Operating Lease, Liability $1.47M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $1.80M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.03M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.24M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.47M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.70M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.93M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.15M 10-K · filed 2025-03-27 |
| 2024-09-30 | $2.37M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.58M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $2.79M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $2.99M 10-K · filed 2024-03-14 |
| 2023-09-30 | $3.04M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.23M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $935.43K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $347.92K 10-K · filed 2023-03-16 |
| 2022-09-30 | $418.82K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $489.17K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $558.97K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |